We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

123 hedge funds and large institutions have $170M invested in Lineage Cell Therapeutics in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

57% more call options, than puts

Call options by funds: $180K | Put options by funds: $115K

14% more capital invested

Capital invested by funds: $149M → $170M (+$21.2M)

10% more funds holding

Funds holding: 112123 (+11)

5.63% more ownership

Funds ownership: 38.5%44.14% (+5.6%)

4% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 28

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
123
Holders Change
+11
Holders Change %
+9.82%
% of All Funds
1.5%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
25
Increased
29
Reduced
28
Closed
12
Calls
$180K
Puts
$115K
Net Calls
+$65K
Net Calls Change
-$500K